# NEOMYCIN SULFATE
> **ANDA204435** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2016-06-10
## Drug
- **FDA Application Number:** ANDA204435
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NEOMYCIN SULFATE
- **Generic name:** NEOMYCIN SULFATE
- **Active ingredients:** NEOMYCIN SULFATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CHARTWELL MOLECULAR
- **Manufacturer:** Chartwell RX, LLC
- **First approval:** 2016-06-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204435)
---
*AI Analytics · CC0 1.0*